Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹416 Cr
P/E Ratio
11.93
P/B Ratio
0.81
Industry P/E
38.62
Debt to Equity
0.08
ROE
6.01 %
ROCE
8.67 %
Div. Yield
0 %
Book Value
384.39
EPS
20.22
CFO
₹574.59 Cr
EBITDA
₹569.39 Cr
Net Profit
₹78.06 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Venus Remedies
| -2.03 | 4.19 | 13.08 | -4.99 | 3.17 | 46.27 | 6.31 |
|
BSE Healthcare
| -6.32 | 2.15 | 5.09 | 19.39 | 20.16 | 22.41 | 10.17 |
|
BSE Small Cap
| -11.87 | 3.53 | 1.67 | 2.22 | 18.83 | 34.77 | 16.11 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Venus Remedies
| -21.39 | 124.32 | -55.70 | 147.53 | 587.19 | -49.55 | -58.37 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 420.95 | 6,882.80 | 25.08 | 12.5 | |
| 5,075.00 | 8,465.68 | 35.79 | 43.77 | |
| 672.25 | 6,576.44 | 74.49 | 4.01 | |
| 659.25 | 6,069.38 | 22.52 | 12.68 |
2 min read•By Research Desk
2 min read•By Research Desk
Venus Remedies Limited engages in the pharmaceutical business in India and internationally. The company offers its products in various therapeutic areas, such as analgesic, analgesic and antipyretic, anti-diabetic, antibiotic, antiemetic, antiviral,... cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormones, immunostimulating agent, iron supplements, muscle relaxant, neurology, oncology, solvent, respiratory, and anticoagulant. It is also involved in the provision of portfolio of herbal products. Venus Remedies Limited was incorporated in 1989 and is headquartered in Panchkula, India. Read more
Incorporated
1989
Chairman
Pawan Chaudhary
Managing Director
Pawan Chaudhary
Headquarters
Chandigarh, Union Territory
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsChange In Email Address Of RTA
18-Apr-2025Intimation Under Regulation 30
04-Feb-2025
The total asset value of Venus Remedies Ltd stood at ₹ 660 Cr as on 31-Dec-24
The share price of Venus Remedies Ltd is ₹312.00 (NSE) and ₹312.55 (BSE) as of 29-Apr-2025 13:04 IST. Venus Remedies Ltd has given a return of 3.17% in the last 3 years.
Venus Remedies Ltd has a market capitalisation of ₹ 416 Cr as on 29-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Venus Remedies Ltd is 0.81 times as on 29-Apr-2025, a 84% discount to its peers’ median range of 5.14 times.
The P/E ratio of Venus Remedies Ltd is 11.93 times as on 29-Apr-2025, a 69% discount to its peers’ median range of 38.62 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Venus Remedies Ltd and enter the required number of quantities and click on buy to purchase the shares of Venus Remedies Ltd.
Venus Remedies Limited engages in the pharmaceutical business in India and internationally. The company offers its products in various therapeutic areas, such as analgesic, analgesic and antipyretic, anti-diabetic, antibiotic, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormones, immunostimulating agent, iron supplements, muscle relaxant, neurology, oncology, solvent, respiratory, and anticoagulant. It is also involved in the provision of portfolio of herbal products. Venus Remedies Limited was incorporated in 1989 and is headquartered in Panchkula, India.
The prominent promoters of Venus Remedies Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
Sunev Pharma Solutions Limited |
17.21%
|
|
Pawan Chaudhary |
12.82%
|
|
Manu Chaudhary |
11.73%
|
The chairman of the company is Pawan Chaudhary, and the managing director is Pawan Chaudhary.
There is no promoter pledging in Venus Remedies Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
8,423
|
|
|
6,920
|
|
|
6,675
|
|
|
6,029
|
| Venus Remedies Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
5.51
|
|
Operating margin(%)
|
4.68
|
|
Net Margin(%)
|
5.23
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Venus Remedies Ltd was ₹35 Cr.
₹-1.20
(
